Quality of Life Issues in Pediatric Immune-Mediated Inflammatory Disease

被引:3
|
作者
Duffy, Ciaran M. [1 ,2 ,3 ]
Wells, George A.
Russell, Anthony S.
Haraoui, Boulos
机构
[1] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada
[2] Univ Ottawa, CHEO Res Inst, Ottawa, ON K1H 8L1, Canada
[3] Univ Ottawa, Inst Heart, Ottawa, ON K1H 8L1, Canada
关键词
QUALITY OF LIFE; OUTCOME ASSESSMENT; JUVENILE RHEUMATOID ARTHRITIS; INFLAMMATORY BOWEL DISEASE; JUVENILE-IDIOPATHIC-ARTHRITIS; GENERIC CORE SCALES; MULTIDIMENSIONAL FATIGUE SCALE; BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; HEALTH-STATUS; CROHNS-DISEASE; MENTAL-HEALTH; CHILDREN; ADOLESCENTS;
D O I
10.3899/jrheum.110905
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been well established that children with a chronic disease, including those with inflammatory bowel disease (IBD) and juvenile idiopathic arthritis (JIA), report lower health-related quality of life (HRQOL) as compared to their healthy peers. Over the past 20 years there has been a significant emphasis on the development of measures of function and HRQOL for application in JIA and pediatric IBD. Several of the instruments currently used to assess HRQOL in children with immune-mediated inflammatory diseases (IMID), including the Juvenile Arthritis Quality of Life Questionnaire (JAQQ) and IMPACT questionnaire for pediatric IBD, were developed and validated by Canadian-based research teams. This review describes several disease-specific and generic instruments used to assess QOL in children with IBD or JIA. It also provides an overview of findings from several outcomes studies that applied the described tools in assessing HRQOL in children and adolescents with these conditions. (J Rheumatol 2011:38:Suppl 88; 20-5; doi:10.3899/jrheum.110905)
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [21] Immune-mediated inflammatory diseases and psoriasis
    Delaporte, E.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 : S269 - S274
  • [22] Inflammatory and Immune-Mediated Cutaneous Diseases
    Quaresma, Juarez A. S.
    Sotto, Mirian N.
    Balato, Anna
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [23] Autoantibodies in immune-mediated inflammatory neuropathies
    Martin-Aguilar, Lorena
    Pascual-Goni, Elba
    Querol, Luis
    MEDICINA CLINICA, 2019, 153 (09): : 360 - 367
  • [24] IMMUNE-MEDIATED MUSCLE DISEASE
    LEWIS, RM
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1994, 24 (04) : 703 - 710
  • [25] Immune-mediated cochleovestibular disease
    Suchan, M.
    Kaliarik, L.
    Krempaska, S.
    Koval, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (02): : 87 - 90
  • [26] Cancer as an immune-mediated disease
    Shurin, Michael R.
    IMMUNOTARGETS AND THERAPY, 2012, 1 : 1 - 6
  • [27] TREATMENT OF IMMUNE-MEDIATED DISEASE
    AUCOIN, DP
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1982, 12 (01) : 61 - 66
  • [28] Immune-Mediated Heart Disease
    Generali, Elena
    Folci, Marco
    Selmi, Carlo
    Riboldi, Piersandro
    IMMUNOLOGY OF CARDIOVASCULAR HOMEOSTASIS AND PATHOLOGY, 2017, 1003 : 145 - 171
  • [29] Is fibromyalgia an immune-mediated disease?
    Trouvin, Anne-Priscille
    Perrot, Serge
    JOINT BONE SPINE, 2022, 89 (04)
  • [30] Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
    Fernando Rizzello
    Ignazio Olivieri
    Alessandro Armuzzi
    Fabio Ayala
    Vincenzo Bettoli
    Luca Bianchi
    Luca Cimino
    Antonio Costanzo
    Antonio Cristaudo
    Salvatore D’Angelo
    Marco Daperno
    Anna Chiara Fostini
    Mauro Galeazzi
    Michele Gilio
    Paolo Gionchetti
    Paolo Gisondi
    Ennio Lubrano
    Antonio Marchesoni
    Annamaria Offidani
    Ambrogio Orlando
    Daniela Pugliese
    Carlo Salvarani
    Raffaele Scarpa
    Maurizio Vecchi
    Giampiero Girolomoni
    Advances in Therapy, 2018, 35 : 545 - 562